Infarmed approves marketing of three cannabis products

Infarmed has authorized the sale of three new medicinal cannabis preparations, bringing the total to four products available in Portugal, as announced to Lusa. Previously, only one preparation with 18% THC and less than 1% CBD had been on the market since 2021. Read more here

If you need more information about medical cannabis regulatory services in the pharmaceutical and healthcare industries, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email

Contact us

We will contact you as soon as possible.